Login / Signup
Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: Commentary.
Jan N Lycke
Anders Svenningsson
Published in:
Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
Keyphrases
</>
combination therapy
nk cells